The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.
A 2022 Physician's Guide to Hopes and Challenges of Cervical Cancer Eradication
When Ovarian Cancer Returns, Surgery May Be a Good Choice for Selected Patients
New Drug Combination Shown to be Effective for Patients with Advanced Ovarian Cancer
Clinical Characteristics, Pregnancy Outcomes & Ovarian Function - A Retrospective Age-Matched Study
Lighting the Way for Improved Detection of Ovarian Cancer
Racial Disparities in Non-Recommendation of Adjuvant Chemotherapy in Ovarian Cancer
Overall Survival and Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer
Ovarian Cancer Update
Certain Cancers Increase Stroke Risk, New Analysis Confirms
Chemo Brain Is Real
Clinical Complications of Chemotherapy and Patient-Reported Outcomes After Breast Reconstruction
Do Annual Screenings Reduce Risk of Death in Ovarian Cancer?
Intrauterine Device May Reduce Ovarian Cancer Risk by 30%
Genital Powder Use and Epithelial Ovarian Cancer
No Survival Benefit from Annual Ovarian Cancer Screening in Low-Risk Women
Women’s Health: 50 Years of Progress
Improved Ovarian Cancer Patient Survival Rates for Patients With bevacizumab
Risk of Late-Onset Breast Cancer in Genetically Predisposed Women
Combination Strategies Reshape Treatment Paradigm for Advanced Endometrial Cancer
Blood Test for Many Cancer Types as Supplement to Screening
